Ropeginterferon alfa-2b (Besremi)

Status:
Red
Decision Date:
July 2020
 

Comments

Monotherapy of polycythaemia vera without symptomatic splenomegaly in adults. 

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app